Abate honored by World Economic Forum at meeting in China

Our faculty member Adam Abate, PhD, was selected by the World Economic Forum (WEF) as one of 45 exceptional Young Scientists—all under the age of 40—each of whom has contributed to advancing the frontiers of science, engineering, or technology in areas of high societal impact.

Abate attended the World Economic Forum’s Ninth Annual Meeting of the New Champions in Dalian, People’s Republic of China, where the Young Scientists were honored in early September.

As a physicist, Abate brings a unique research program to our campus. His work employs dro­­plet-based microfluidics for high-throughput biological applications. He has developed methods using microdroplets—tiny spheres of aqueous liquid surrounded by inert oil—as tiny “test tubes” for performing chemical and biological reactions. This allows multiple, independent reactions to take place at the rate of thousands per second. The Abate Lab is using this approach for directed evolution, genetic sequencing, and cell sorting.

Abate joined the faculty in 2011, in the Department of Bioengineering and Therapeutic Sciences, a joint department of the UCSF Schools of Pharmacy and Medicine. He earned a PhD in Physics at the University of Pennsylvania in 2006, an MS in Physics from UCLA in 2004, and a BA in Physics at Harvard in 2002.

Commenting on the honor, Department Chair Tejal Desai, PhD, said, “We are exceedingly proud of Adam. I am delighted to join the WEF in acknowledging his achievements and thanking him for his many contributions to advancing health worldwide.”


[World Economic Forum Honours its 2015 Young Scientists Community at Annual Meeting of the New Champions][link defunct]


Department of Bioengineering and Therapeutic Sciences, PharmD Degree Program, UCSF - UC Berkeley Joint Graduate Group in Bioengineering, Biophysics Graduate Program (BP), Pharmaceutical Sciences and Pharmacogenomics Graduate Program (PSPG), Biophysics, PSPG

About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.